Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Chris Argent
Scientia Clinical Research Ltd
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
115
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old
Number of pages: 38
Posted: 21 Mar 2024
Nick Wood
,
Ushma Wadia
,
Peter Richmond
, Chris Argent,
Helen S. Marshall
,
Kerrie J. Sandgren
,
Katie Tungatt
,
Gabriela Martins Costa Gomes
,
Will Asquith
,
Janette Taylor
,
Matthew V. O'Sullivan
,
Dominic Dwyer
,
Anita H.J. van den Biggelaar
,
Laurent Dapremont
,
Souad Mansouri
,
Pham Hong Thai
and
Anthony L. Cunningham
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, The University of Western Australia, Scientia Clinical Research Ltd, University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - NSW Health Pathology, The University of Sydney - Westmead Hospital, The University of Sydney - Sydney Infectious Diseases Institute, The University of Sydney - Westmead Hospital, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, Technovalia Pty. Ltd., Technovalia Pty. Ltd., BioNet-Asia Co Ltd and The University of Sydney - Westmead Institute for Medical Research
Downloads
115
(617,542)
View PDF
Download
Abstract:
DNA, SARS-CoV-2, vaccine, neutralising antibody, COVID-19, safety, immunogenicity
Feedback